HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 2006-0026v1 24/12/2733    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuwana, M. Articles by Ikeda, Y. Search for Related Content PubMed PubMed Citation Articles by Kuwana, M. Articles by Ikeda, Y.

TISSUE-SPECIFIC STEM CELLS

Endothelial Differentiation Potential of Human Monocyte-Derived Multipotential Cells

Divisions of ^aRheumatology,
^bCardiology, and
^cHematology, Department of Internal Medicine, and
^dInstitute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan

Key Words. Endothelial differentiation • Endothelial cells • Monocyte • Vascularization

Correspondence: Masataka Kuwana, M.D., Ph.D., Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Telephone: 81-3-3350-3567; Fax: 81-3-3350-3567; e-mail: kuwanam{at}sc.itc.keio.ac.jp

Received January 12, 2006; accepted for publication July 27, 2006.
First published online in STEM CELLS EXPRESS   August 3, 2006.



We previously reported a unique CD14⁺CD45⁺CD34⁺ type I collagen⁺ cell fraction derived from human circulating CD14⁺ monocytes, named monocyte-derived multipotential cells (MOMCs). This primitive cell population contains progenitors capable of differentiating along the mesenchymal and neuronal lineages. Here, we investigated whether MOMCs can also differentiate along the endothelial lineage. MOMCs treated with angiogenic growth factors for 7 days changed morphologically and adopted a caudate appearance with rod-shaped microtubulated structures resembling Weibel-Palade bodies. Almost every cell expressed CD31, CD144, vascular endothelial growth factor (VEGF) type 1 and 2 receptors, Tie-2, von Willebrand factor (vWF), endothelial nitric-oxide synthase, and CD146, but CD14/CD45 expression was markedly downregulated. Under these culture conditions, the MOMCs continued to proliferate for up to 7 days. Functional characteristics, including vWF release upon histamine stimulation and upregulated expression of VEGF and VEGF type 1 receptor in response to hypoxia, were indistinguishable between the MOMC-derived endothelial-like cells and cultured mature endothelial cells. The MOMCs responded to angiogenic stimuli and promoted the formation of mature endothelial cell tubules in Matrigel cultures. Finally, in xenogenic transplantation studies using a severe combined immunodeficient mouse model, syngeneic colon carcinoma cells were injected subcutaneously with or without human MOMCs. Cotransplantation of the MOMCs promoted the formation of blood vessels, and more than 40% of the tumor vessel sections incorporated human endothelial cells derived from MOMCs. These findings indicate that human MOMCs can proliferate and differentiate along the endothelial lineage in a specific permissive environment and thus represent an autologous transplantable cell source for therapeutic neovasculogenesis.

This article has been cited by other articles:

				Errata J. Leukoc. Biol., December 1, 2008; 84(6): 1623a - 1623. [Full Text] [PDF]

				R. Miller, V. Cirulli, G. R. Diaferia, S. Ninniri, G. Hardiman, B. E. Torbett, R. Benezra, and L. Crisa Switching-On Survival and Repair Response Programs in Islet Transplants by Bone Marrow-Derived Vasculogenic Cells Diabetes, September 1, 2008; 57(9): 2402 - 2412. [Abstract] [Full Text] [PDF]

				D. Voskas, Y. Babichev, L. S. Ling, J. Alami, Y. Shaked, R. S. Kerbel, B. Ciruna, and D. J. Dumont An eosinophil immune response characterizes the inflammatory skin disease observed in Tie-2 transgenic mice J. Leukoc. Biol., July 1, 2008; 84(1): 59 - 67. [Abstract] [Full Text] [PDF]

				R. Riccioni, D. Diverio, G. Mariani, S. Buffolino, V. Riti, E. Saulle, E. Petrucci, M. Cedrone, F. Lo-Coco, R. Foa, et al. Expression of Tie-2 and Other Receptors for Endothelial Growth Factors in Acute Myeloid Leukemias Is Associated with Monocytic Features of Leukemic Blasts Stem Cells, August 1, 2007; 25(8): 1862 - 1871. [Abstract] [Full Text] [PDF]

				C. Murdoch, S. Tazzyman, S. Webster, and C. E. Lewis Expression of Tie-2 by Human Monocytes and Their Responses to Angiopoietin-2 J. Immunol., June 1, 2007; 178(11): 7405 - 7411. [Abstract] [Full Text] [PDF]

				J. C. McAuliffe and J. C. Trent Biomarkers in Gastrointestinal Stromal Tumor: Should We Equate Blood-Based Pharmacodynamics with Tumor Biology and Clinical Outcomes? Clin. Cancer Res., May 1, 2007; 13(9): 2535 - 2536. [Full Text] [PDF]